A ‘Moonshot’ for Mental Health Care: Leaving No Veteran Behind

Three people chatting

At the Road Home Program: The National Center of Excellence for Veterans and Their Families at Rush, around 84% of veterans and active-duty service members report experiencing meaningful improvement following treatment for post-traumatic stress disorder, or PTSD. While these are celebrated, industry-leading numbers, an important question remains for Road Home Program researchers: How can they help the remaining clients? 

“What keeps us up at night is that 16% of individuals don't get better,” said Philip Held, PhD, director of research and innovation at the Road Home Program. 

This group of participants is often referred to as non-optimal responders because they may continue to struggle following treatment despite making small, and often meaningful, improvements. 

“They will leave treatment and say, ‘I feel a little bit better. I'm now able to go to family events, but I definitely don’t want to go to a Bears game because that’s still a pretty frightening experience,’” Dr. Held explained. “We’re trying to find the optimal treatment for these individuals.” 

In May 2026, the Road Home Program received a transformative opportunity to do just that. The program was awarded a highly competitive federal grant of up to $4 million from the Advanced Research Projects Agency for Health (ARPA-H). ARPA-H seeks to support high-risk, high-reward, innovative projects in biomedical and health research. These “moonshot” projects aim to deliver breakthrough health solutions quickly. 

Ultimately, Road Home’s project aims to help more veterans achieve lasting recovery by bringing precision medicine to PTSD care. Through the project, researchers will develop tools to predict which individuals are most likely to have lasting improvement after accelerated treatment and who may be at higher risk for symptom recurrence. This will allow clinicians to more precisely tailor treatment to each individual, which could lead to more participants feeling better. 

Accessing new data streams for more precise treatment 

The Road Home Program has worked extensively on machine learning and artificial intelligence to predict treatment response. 

“We have algorithms that can do this fairly successfully,” Dr. Held said. “These algorithms still come with quite a bit of error. We want to make sure that we reduce errors as much as possible and that we're able to present reliable information to the veterans and service members themselves so that they can make informed decisions about which type of treatment they will ultimately want.” 

The focus of Dr. Held’s research with the ARPA-H grant is to access more data streams, increasing the reliability of these algorithms in predicting how individual veterans will respond to treatment. 

In the past, Road Home clinicians have had to rely on self-reporting measures and electronic health records. 

“It's fairly limiting because when you think about what goes on in psychotherapy, it's not so much what you put into a self-report survey,” Dr. Held said. “It's much more about what you talk about and how you talk about it. And from audio, we can glean a lot of information, but that is usually not captured.” 

With ARPA-H, researchers will now be able to capture this audio-based information from sessions to identify important markers that might indicate success, and the algorithm will assess patterns. 

In addition to audio, Road Home researchers are adding two other data streams from wearable devices. Data from standard fitness trackers like Apple Watches or Oura Rings will allow researchers to observe participants’ physiology throughout the course of treatment. And data from an EEG device worn during treatment — essentially four stickers placed on the head — allows insight into the processing that occurs in participants’ brains. 

Jennifer Coleman, PhD, clinical director at the Road Home Program, noted that all aspects of participation will be completely voluntary, and the data will be stored securely. 

“Patients can opt in or opt out at any point to various things,” she said. 

But, she added, the veterans, service members and families served by Road Home are often enthusiastic about participating in research. 

“They want to advance the science and help other people,” she said. 

Dr. Held explained that with all of these extra data streams, they’ll be able to take a more complete look at participants beyond what is normal in psychotherapy treatment. 

“Through this more in-depth look, we are confident that we can get much better estimates for whether you will respond to treatment, and if you don't, what might be a more optimal type of treatment for you,” he said. “It's not that the computer makes the determination. It's just providing an additional point of reference that helps in the decision-making process for the optimal treatment. It’s similar to cancer treatment. Based on the type of cancer you have, you will get a recommendation for a certain type of treatment. And oftentimes, it comes with the chance of success of that particular treatment. And then the patient still gets to decide, ‘Well, that's good enough for me to try,’ or ‘I'd rather try option two or three.’” 

That's essentially what Dr. Held and the other researchers are trying to bring to PTSD treatment: a more informed approach about what treatment options will likely be beneficial for each participant. 

Dr. Coleman is excited about advancing what machine learning can do for the veterans and active-duty service members who they treat. 

“A clinician may think they know the best route to go, and think, ‘I'm going to focus on this certain belief,’” she said, referring to the cognitive behavioral therapy practice of focusing on beliefs to unlearn unhelpful patterns of thought. “But some of his technology has helped them to use machine learning to say, ‘Actually, that's not quite the optimal belief to focus on.’ And so it really specifies what is useful for the clinician to use in therapy.” 

Accelerating innovation with philanthropic investment 

Flexible philanthropic funding was key to helping the Road Home team secure this grant, as it allowed them to accelerate the speed at which they generated pilot data. 

In the traditional academic model, it can take years to write, submit and edit a grant before it gets funded, and additional years beyond that to collect pilot data. 

“What philanthropic dollars allow us to do is to generate this pilot data really quickly,” Dr. Held said. “It positions us well, so we're going into different applications with enough data to base our hypotheses on and to show that this can actually work. So that evokes a lot of confidence in funders because they can say, ‘You have tried this, and it looks promising enough, and we're willing to put our money behind it.’” 

Philanthropic funders catapulted the Road Home Program into a position to compete for a moonshot grant like ARPA-H, and Dr. Held pointed out that the Road Home team won’t slow down anytime soon. ARPA-H is a short-term grant, unlike traditional NIH grants. 

“The goal here is to essentially move mountains in a very short amount of time,” he said. 

And this is something Road Home has a track record of doing. The standard is generally 17 years between a scientific finding and its adoption in clinical care. Road Home turns its scientific insights into clinical practice in about three years. 

Dr. Coleman said she finds it difficult to put into words what an exciting moment this is. 

“What we do every day at Road Home, our baseline is above and beyond,” she said. “This precision learning and this taking us to the moon is really leaps above what most people in the field are doing. We're very well known in the PTSD field, but I think ARPA takes it to another level.”

To learn more about supporting the Road Home Program’s work to provide mental health care at no cost to veterans, active-duty service members and families, please contact Michelle Boardman, senior director of development, at michelle_a_boardman@rush.edu or (312) 942-6884. You may also make a gift online to fuel services and innovation at the Road Home Program.